Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Neoplasia (New York, N.Y.)|April 9, 2014
KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated β-TrCP1 degradationShirish Shukla, Uday Sankar Allam, Aarif Ahsan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 24, 2014
Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantationCraig J Galbán, Jennifer L Boes, Maria Bule, et al.
Translational Oncology|November 13, 2014
A pilot study of diffusion-weighted MRI in patients undergoing neoadjuvant chemoradiation for pancreatic cancerKyle C Cuneo, Thomas L Chenevert, Edgar Ben-Josef, et al.
Molecular Cancer Therapeutics|June 19, 2003
Evaluation of cancer therapy using diffusion magnetic resonance imagingBrian D Ross, Bradford A Moffat, Theodore S Lawrence, et al.
Molecular Imaging|August 21, 2003
Diffusion MRI: a new strategy for assessment of cancer therapeutic efficacyThomas L Chenevert, Charles R Meyer, Bradford A Moffat, et al.
Nature Immunology|October 23, 2021
Mitochondrial complex II in intestinal epithelial cells regulates T cell-mediated immunopathologyHideaki Fujiwara, Keisuke Seike, Michael D Brooks, et al.
Neoplasia (New York, N.Y.)|January 9, 2023
Subclonal evolution and expansion of spatially distinct THY1-positive cells is associated with recurrence in glioblastomaWajd N Al-Holou, Hanxiao Wang, Visweswaran Ravikumar, et al.
Plos One|June 19, 2013
Imaging proteolytic activity in live cells and animal modelsStefanie Galbán, Yong Hyun Jeon, Brittany M Bowman, et al.
Cell Reports|January 12, 2022
ATRX loss in glioma results in dysregulation of cell-cycle phase transition and ATM inhibitor radio-sensitizationTingting Qin, Brendan Mullan, Ramya Ravindran, et al.
Molecular Cancer Therapeutics|December 17, 2024
Olaparib and Radiotherapy Induce Type I Interferon- and CD8+ T Cell-Dependent Sensitization to Immunotherapy in Pancreatic CancerVictoria M Valvo, Qiang Zhang, Long Jiang, et al.
Pageof 16